Financial Data and Key Metrics Changes - Third quarter sales reached $3.1 billion, reflecting a 6% organic growth year-over-year [5][12] - Operating EBITDA was $840 million, an increase of 6% year-over-year, resulting in an operating EBITDA margin of 27.3% [5][12] - Adjusted EPS for the quarter was $1.09, flat compared to the previous year, primarily due to a higher tax rate [14] Business Line Data and Key Metrics Changes - **Industrials Co.**: Net sales of $1.8 billion, up 5% year-over-year, with 4% organic growth [14][16] - **Electronics Co.**: Net sales of $1.3 billion, an increase of 11% year-over-year, driven by 10% organic growth [17] - Organic growth in healthcare and water technologies was in the high single digits, while diversified industrials saw low single-digit growth [15][16] Market Data and Key Metrics Changes - North America and Asia-Pacific regions experienced 7% organic growth, while Europe saw a 6% increase year-over-year [13] - The healthcare and water business is expected to grow at about 5% organic growth on average [31] Company Strategy and Development Direction - The company is focused on driving above-market organic growth and building a robust business system [7][11] - A disciplined capital allocation model was emphasized, including a quarterly dividend of $0.20 per share and a $2 billion share repurchase authorization [6][11] - The company aims for medium-term targets of 3%-4% organic growth, 150-200 basis points of margin expansion, and 8%-10% EPS growth from 2026 to 2028 [11][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving medium-term targets, with expectations of continued growth in healthcare and water sectors [31][92] - The construction market is anticipated to improve, with expectations of flat performance in the shelter business next year [82][93] Other Important Information - The successful completion of the CUNY separation was highlighted, with $4.2 billion received to reduce debt [18] - The company is actively pursuing M&A opportunities, particularly in healthcare and water sectors [41][53] Q&A Session Summary Question: Can you provide insight on the timing benefit in sales? - The timing benefit was customer-driven, as orders were accelerated into Q3 due to a planned blackout period for the separation [29] Question: What are the expectations for 2026? - The company expects healthcare and water to grow at about 5% organic growth, while the diversified industrials segment is projected to be flat [31][92] Question: What is the plan for the balance sheet? - The pro forma debt is expected to be around $3.25 billion, with a target to stay below 2 times net debt to EBITDA [39] Question: Can you elaborate on the RO acquisition in China? - The acquisition was primarily to add capacity and enhance local production capabilities, not to introduce new technology [97] Question: How is the healthcare business performing? - The healthcare business is expected to see mid to high single-digit growth, with strong performance in medical packaging and biopharma [80]

Financial Performance - Net sales reached $3.072 billion, a 7% increase compared to the previous year[65] - Organic sales grew by 6%, driven by electronics, healthcare, water, and industrials end-markets[14] - Operating EBITDA increased by 6% year-over-year to $840 million, attributed to organic growth and productivity[15] - Adjusted EPS remained consistent at $1.09 per share, with higher segment earnings offset by a higher tax rate[15] - Transaction-adjusted free cash flow from continuing operations was $576 million, representing a 126% conversion rate[15] Business Segments - IndustrialsCo's organic sales increased by 4%[15] - ElectronicsCo's organic sales increased by 10%[15] - Healthcare & Water Technologies sales increased by high-single digits organically[21] - Diversified Industrials sales increased by low-single digits organically[21] Strategic Initiatives - DuPont completed the spin-off of its Electronics business, Qnity, on November 1, 2025[3] - A definitive agreement was reached to sell the aramids business to TJC LP for approximately $1.2 billion in cash, a $300 million note, and a minority equity interest valued at $325 million[4] - A $2 billion share repurchase authorization was announced, with an initial $500 million accelerated share repurchase (ASR) expected to launch quickly[10] Guidance - Full-year 2025 operating EBITDA guidance was raised to approximately $1.6 billion[28] - Full-year 2025 net sales are projected to be approximately $6.840 billion[29] - Full-year 2025 adjusted EPS is projected to be approximately $1.66[29]

DuPont reports third-quarter earnings per share of $1.09 from sales of $3.1 billion. Results aren't comparable to consensus estimates with the Qnity Electronics spinoff completed earlier in the week. ...

格隆汇11月6日｜杜邦公司：第三季度销售额为30.7亿美元。预计第四季度调整后每股收益约为43美 分。 ...

Core Insights - DuPont de Nemours reported an increase in third-quarter sales, indicating positive performance in the market [1] - The company authorized a stock repurchase program worth $2 billion, reflecting confidence in its financial health and future prospects [1] - A quarterly dividend of 20 cents per share was declared, demonstrating a commitment to returning value to shareholders [1]

Financial Performance - DuPont reported strong third-quarter 2025 financial results, with sales of $3.07 billion, surpassing the estimated $2.90 billion [2][9] - Adjusted earnings per share (EPS) for DuPont were $1.09, exceeding forecasts of $1.06 [2][9] - Operating EBITDA reached $840 million, slightly above the estimate of $839.7 million [2][9] - DuPont's outlook for the fourth quarter projects net sales of approximately $1.69 billion and adjusted EPS of about $0.43, both slightly below analyst expectations [2][9] Regulatory Developments - The European Commission has initiated a formal antitrust investigation into Deutsche Boerse and Nasdaq, focusing on potential collusion in the listing, trading, and clearing of financial derivatives [3][9] - Concerns include possible agreements not to compete, allocation of demand, coordinated pricing, and the exchange of commercially sensitive information [3][9] Market Trends - Soybean prices surged to their highest point in 17 months, driven by expectations of renewed large-scale U.S. soybean purchases by China [4][9] - U.S. stock futures turned positive, indicating a generally optimistic market sentiment, with S&P 500 E-mini futures up 0.08%, Nasdaq 100 futures gaining 0.07%, and Dow futures seeing a 0.01% increase [5][9] Economic Impact - The Bank of Italy commented on the government's tax hike measures, indicating that these are expected to affect the banking sector, while the impact on insurers is projected to be limited [6][9] - The Italian government's 2026 budget plans include an €11 billion ($12.8 billion) tax increase on banks and insurance firms over 2026-2028 [6][9]

Financial Performance - Net sales for Q3 2025 were $3.1 billion, a 7% increase year-over-year, with organic sales growth of 6%[4] - GAAP income from continuing operations decreased to $308 million, down 32% from $453 million in Q3 2024[3] - Operating EBITDA increased to $840 million, reflecting a 6% growth compared to $791 million in the prior year[3] - The company raised its full-year 2025 operating EBITDA guidance to approximately $1.6 billion[4] - DuPont reported net sales of $3,072 million for Q3 2025, a 7.3% increase from $2,862 million in Q3 2024[48] - Income from continuing operations before income taxes decreased to $327 million in Q3 2025 from $552 million in Q3 2024, a decline of 40.7%[48] - The adjusted earnings per share (EPS) for Q3 2025 was $0.70, compared to $1.06 in Q3 2024, a decrease of 34%[48] - DuPont's net loss attributable to common stockholders was $123 million in Q3 2025, compared to a net income of $455 million in Q3 2024[48] - The company reported a loss from discontinued operations of $415 million in Q3 2025, contrasting with a gain of $12 million in Q3 2024[48] - Total net sales for the nine months ended September 30, 2025, reached $8,720 million, a 5.5% increase compared to $8,263 million in the prior year[54] - Operating EBITDA for the nine months ended September 30, 2025, was $2,361 million, up from $2,124 million in the same period of 2024, reflecting an increase of 11.2%[57] - For the nine months ended September 30, 2025, reported losses (GAAP) were $938 million, compared to earnings of $1,041 million in the same period of 2024[73] Cash Flow and Dividends - Transaction-adjusted free cash flow for the quarter was $576 million, with a conversion rate of 126%[7] - Cash provided by operating activities from continuing operations was $1,260 million for the nine months ended September 30, 2025, compared to $1,517 million in 2024, indicating a decrease of 16.9%[52] - Cash provided by operating activities for Q3 2025 was $591 million, down from $665 million in Q3 2024, representing a decrease of 11.1%[61] - Adjusted free cash flow for Q3 2025 was $445 million, a decline of 21.4% compared to $566 million in Q3 2024[61] - The adjusted free cash flow conversion rate for Q3 2025 was 97%, down from 123% in Q3 2024[61] - A quarterly dividend of $0.20 per share was declared, aligning with a targeted payout ratio of 35%-45%[10] Costs and Expenses - The cost of sales for Q3 2025 was $1,877 million, up from $1,739 million in Q3 2024, reflecting a 7.9% increase[48] - Research and development expenses increased to $140 million in Q3 2025 from $127 million in Q3 2024, a rise of 10.2%[48] - The company incurred acquisition, integration, and separation costs of $139 million in Q3 2025, significantly higher than $43 million in Q3 2024[48] - Acquisition, integration, and separation costs for the nine months ended September 30, 2025, totaled $383 million, significantly impacting reported losses[73] - The company incurred $131 million in separation-related transaction costs for Q3 2025, compared to $12 million in Q3 2024[61] Assets and Liabilities - Total assets increased to $38,044 million as of September 30, 2025, up from $36,636 million at December 31, 2024, representing a growth of 3.9%[50] - Total current liabilities increased to $5,005 million as of September 30, 2025, from $4,887 million at December 31, 2024, marking a rise of 2.4%[50] - Long-term debt rose significantly to $7,049 million as of September 30, 2025, compared to $5,323 million at December 31, 2024, an increase of 32.5%[50] - The company’s accumulated deficit increased to $(23,728) million as of September 30, 2025, compared to $(23,076) million at December 31, 2024[50] Market Performance - ElectronicsCo achieved 10% organic sales growth, while IndustrialsCo saw 4% organic sales growth[11] - DuPont's operational improvements and strong performance in healthcare and water end-markets contributed to the positive outlook despite challenges in construction markets[23] - Net sales in the Asia Pacific region for the nine months ended September 30, 2025, were $4,020 million, up from $3,767 million in 2024, reflecting a growth of 6.7%[54] Future Outlook - The company expects full-year net sales to be approximately $6.84 billion, reflecting a slight decrease from prior guidance[21] - The company plans to continue its focus on the Electronics Separation and Distribution, which is expected to impact its future capital structure and operational efficiencies[30]

Core Insights - DuPont de Nemours, Inc. operates in the technology-based materials and solutions industry, divided into three segments: Electronics & Industrial, Mobility & Materials, and Water & Protection, serving various industries globally [1] - The consensus price target for DuPont has fluctuated significantly, dropping from $79.6 to $47 recently, indicating a shift in analyst sentiment, although Deutsche Bank analyst David Begleiter maintains a higher target of $90 [2][6] - The average price target comparison shows a decrease from $82.5 last year to $79.6 last quarter, suggesting a stable long-term outlook despite immediate concerns reflected in the recent drop [3][4] Financial Performance Expectations - DuPont is expected to release its third-quarter 2025 earnings results soon, with forecasts of earnings at $1.13 per share and revenue around $3.1 billion [3][6] - The company's history of exceeding earnings expectations may positively influence future price targets [3][5] Market Influences - Various factors such as market dynamics, company performance, and economic conditions are influencing changes in price targets for DuPont [4][5] - Upcoming earnings reports and strategic decisions are critical for understanding the company's current standing and future prospects [5]

Wall Street analysts forecast that DuPont de Nemours (DD) will report quarterly earnings of $1.04 per share in its upcoming release, pointing to a year-over-year decline of 11.9%. It is anticipated that revenues will amount to $2.63 billion, exhibiting a decrease of 17.7% compared to the year-ago quarter.The consensus EPS estimate for the quarter has been revised 15.1% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their init ...

We recently published 10 Firms Stealing Market Spotlight Amid Bloodbath. DuPont de Nemours, Inc. (NYSE:DD) is one of the best-performing stocks on Tuesday. DuPont saw its share prices jump to a new all-time high on Tuesday as investors loaded portfolios ahead of its third-quarter earnings performance and following announcements that it successfully completed the separation of its electronics business, Qnity Electronics Inc. At intra-day trading, DuPont de Nemours, Inc. (NYSE:DD) jumped to its highest 52- ...